BioNTech
harnessing the power of the immune system to address serious diseases infectious disease oncology | BioNTech
Company
Deck Type
Sector
Industry
Deck date
November 2021
Slide
8 of 40
Related slides by other companies
Embracer Group
Results
August 2023
program focus areas and phases main focus areas being addressed in phases and savings capital allocation efficiency improvements clearly defined structure in place under leadership of executive management with the engagement and commitment of senior management from across the group | Embracer Group
DICE Therapeutics
Investor Presentation
March 2023
| DICE Therapeutics
Apexigen
Investor Presentation
September 2022
our most advanced phase programs | Apexigen
ATAI
Investor Presentation
October 2023
program status phase expected in clinical trial design results | ATAI
Other recent decks by BioNTech
See all presentations (12 decks)
Investor Presentation
August 2022
Results
August 2022
Investor Day
June 2022
Results
March 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io